Waguih IsHak

Professor of Psychiatry

Cedars-Sinai Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Waguih IsHak is a Professor of Psychiatry at Cedars-Sinai Medical Center in the United States. His research focuses on a range of psychiatric conditions, including bipolar disorder, anxiety disorders, and schizophrenia, with a particular emphasis on the effectiveness of psychiatric medications and innovative treatment approaches. His recent publications investigate the role of artificial intelligence in predicting suicide and evaluate the management of opioid use disorder. Dr. IsHak is dedicated to advancing the field of psychiatry through systematic reviews and clinical trials.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (1)

Michael Ong

Staff Physician / Associate Chief of Staff for Research

VA Greater Los Angeles Healthcare System

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Waguih IsHak

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Bipolar disorder: Systematic review of approved psychiatric medications (2008-2024) and pipeline Phase-3 medications.

Sleep-wake Disorders: Systematic Review of Approved Psychiatric Medications (2008 to 2024) and Pipeline Phase-3 Medications.

Evaluating the ability of artificial intelligence to predict suicide: A systematic review of reviews.

Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial.

Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008-2024) and pipeline phase III medications.

Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024).

Comparative Effectiveness of Psychotherapy vs Antidepressants for Depression in Heart Failure

Systematic review of long-acting injectable antipsychotic medications approved from 2008 to october 2024 and agents in phase 3.

Quality of Life and Functioning Impairments Across Psychiatric Disorders in Adults Presenting for Outpatient Psychiatric Evaluation and Treatment

The addiction consultation service for hospitalized patients with substance use disorder: An integrative review of the evidence.

Collaborators (1)

Michael Ong

Make your next move.